Strategic partnerships 1MED actively engages in alliances with technology and service providers, such as Circular Protocol and Accenture, signaling openness to co-deliver solutions and access broader client ecosystems. This creates entry points for joint offerings and referral opportunities in regulated MedTech projects and digital data integrity initiatives.

Digital data leadership The launch of 1SURVEY a Real-World Data collection tool positions 1MED as a provider of data-driven clinical insights. Sales opportunities exist in hospitals and CROs seeking robust RWD capture, registry support, and seamless integration with existing EHRs and regulatory workflows.

Regulatory and quality reach With services spanning regulatory support, quality management, clinical trial management, and post-market activities, 1MED can cross-sell end-to-end compliance and lifecycle management to MedTech manufacturers aiming to accelerate time to market and maintain certification across Europe.

Data integrity partnerships Recent collaboration with Circular Global Ledgers indicates emphasis on secure, auditable clinical data. This aligns with sales opportunities for customers prioritizing data provenance, traceability, and tamper-evident records in clinical studies and post-market surveillance.

Mid-market focus With 51-200 employees and a revenue band of 25–50 million USD, 1MED targets mid-market MedTech firms seeking scalable development and digital solutions, suggesting growth via tiered service packages, trainings, and platform-based offerings to capture a broader European market.